Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...

Senator Hawley may view international price referencing for prescription drugs in Medicaid as a way to spare deep cuts in ...

It’s drawn the industry off the sidelines, with several senior executives preparing to barnstorm Capitol Hill this week, ...